QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
종목 코드 QDEL
회사 이름QuidelOrtho Corp
상장일Feb 01, 1991
CEOMr. Brian J. Blaser
직원 수6600
유형Ordinary Share
회계 연도 종료Feb 01
주소9975 Summers Ridge Road
도시SAN DIEGO
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호92121
전화18585521100
웹사이트https://www.quidelortho.com/
종목 코드 QDEL
상장일Feb 01, 1991
CEOMr. Brian J. Blaser
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음